Columbia University Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, New York, NY, 10032, USA,
Curr Cardiol Rep. 2014 May;16(5):475. doi: 10.1007/s11886-014-0475-6.
Despite the higher incidence of paravalvular regurgitation (PVR) with transcatheter aortic valve replacement (TAVR), this novel treatment modality has rapidly emerged as a reasonable alternative to surgical aortic valve replacement (SAVR) in high risk and inoperable patients. This review will discuss the current literature with respect to assessment, outcomes, predictors, and intraprocedural treatment options of PVR following TAVR. Understanding the predictors may help reduce the incidence of PVR and improving the outcome of this procedure.
尽管经导管主动脉瓣置换术（TAVR）后瓣周漏（PVR）的发生率较高，但这种新型治疗方法已迅速成为高危和不可手术患者外科主动脉瓣置换术（SAVR）的合理替代方法。本文将讨论目前关于 TAVR 后 PVR 的评估、结果、预测因素和术中治疗选择的文献。了解预测因素可能有助于降低 PVR 的发生率并改善该手术的结果。
